All articles tagged with #xfg variant
Updated COVID vaccines targeting the XFG variant are available for adults 65 and older and those with underlying conditions, though CDC guidance remains limited. Medical groups recommend annual shots for broader populations to prevent severe illness during the winter surge.
The FDA has approved four updated COVID-19 vaccines for the 2026-2027 season, all targeting the JN.1-lineage XFG variant. These shots are now available at major pharmacies and are recommended for adults 65 and older, as well as younger individuals with underlying health conditions or those who are pregnant. While the CDC has not issued new guidance due to the dissolution of the Advisory Committee on Immunization Practices, major medical associations have issued recommendations mirroring previous protocols. Experts advise getting the vaccine in September or October to ensure protection before the winter surge, noting that the shots are safe and covered by most insurance plans.
The FDA has approved updated COVID-19 vaccines from Pfizer-BioNTech, Moderna, and Sanofi for older adults and individuals with underlying health conditions. These shots target the dominant XFG variant and are expected to reach pharmacies within days. While federal recommendations remain unclear due to legal disputes over the vaccine advisory panel, major medical societies continue to support vaccination for high-risk groups, and insurers have pledged coverage.
The FDA has approved updated COVID-19 vaccines from Moderna, Pfizer-BioNTech, and Novavax-Sanofi targeting the dominant XFG variant. The shots are approved for adults 65 and older, and younger individuals with underlying health conditions. While manufacturers have begun shipping doses for the 2026-27 season, the absence of a formal CDC recommendation due to legal disputes over the vaccine advisory panel creates uncertainty regarding insurance coverage and pharmacy access in some states.
U.S. COVID-19 cases are rising in late 2026, driven by the XFG variant. While respiratory symptoms persist, doctors report a notable increase in gastrointestinal issues like nausea and vomiting. Experts advise standard precautions and home care, noting the current wave is less severe than previous years.
Swiss Covid experts recommend reintroducing face masks during winter to curb rising cases, especially for vulnerable groups, as UK reports an increase in Covid infections driven by the new XFG strain, which currently poses low additional risk according to WHO.
The new COVID-19 variant XFG, originating from the Omicron family and spreading mainly in Southeast Asia, is under WHO monitoring due to its potential to spread more easily. While it currently poses a low immediate risk, it contains additional mutations and is growing globally. Existing vaccines and antiviral treatments are expected to offer some protection against severe disease from XFG, though research is ongoing.